Skip to main content
SpringerLink
Log in

Importance of Adequate Lymphadenectomy in Gastrointestinal Cancer

  • Chapter
  • First Online:
Gastrointestinal Malignancies

Part of the book series: Cancer Treatment and Research ((CTAR))

Abstract

One of the most important factors influencing cancer-specific survival in the field GI oncology is the presence of positive lymph nodes. Although it remains controversial, adequate lymph node examination is required for accurate staging such that patients can receive correct adjuvant treatments and for stratification in clinical trials. Nevertheless, wide variation in the quality of lymph node examination exists in the US and many centers are not meeting guideline treatment recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29

    Article  PubMed  Google Scholar 

  2. Senthil M, Trisal V, Paz IB, Lai LL (2010) Prediction of the adequacy of lymph node retrieval in colon cancer by hospital type. Arch Surg 145(9):840–843

    Article  PubMed  Google Scholar 

  3. Halsted WSI (1907) The results of radical operations for the cure of carcinoma of the breast. Ann Surg 46(1):1–19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Fisher B, Fisher ER (1966) Transmigration of lymph nodes by tumor cells. Science 152(727):1397–1398

    Article  CAS  PubMed  Google Scholar 

  5. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347(8):567–575

    Article  PubMed  Google Scholar 

  6. American Joint Committee on Cancer (AJCC). Available at http://www.cancerstaging.org. Last Accessed 1 July 2015

  7. Hofstetter W, Correa AM, Bekele N et al (2007) Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84(2):365–373 (discussion 374–365)

    Google Scholar 

  8. Mariette C, Piessen G, Briez N, Triboulet JP (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247(2):365–371

    Article  PubMed  Google Scholar 

  9. Rizk NP, Ishwaran H, Rice TW et al (2010) Optimum lymphadenectomy for esophageal cancer. Ann Surg 251(1):46–50

    Article  PubMed  Google Scholar 

  10. Peyre CG, Hagen JA, DeMeester SR et al (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248(4):549–556

    PubMed  Google Scholar 

  11. Barbour AP, Rizk NP, Gonen M et al (2007) Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol 14(2):306–316

    Article  PubMed  Google Scholar 

  12. The national comprehensive cancer network guidelines in oncology. Available at: http://www.nccn.org. Last accessed 1 July 2015

  13. AJCC cancer staging manual, 7th edn. Springer, Chicago IL, 2010

    Google Scholar 

  14. Merkow RP, Bilimoria KY, McCarter MD, Chow WB, Ko CY, Bentrem DJ (2011) Use of Multimodality neoadjuvant therapy for esophageal cancer in the United States: assessment of 987 hospitals. Ann Surg Oncol

    Google Scholar 

  15. Koen Talsma A, Shapiro J, Looman CW et al (2014) Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg 260(5):786–792 (discussion 792–783)

    Google Scholar 

  16. Merkow RP, Bilimoria KY, Chow WB et al (2012) Variation in lymph node examination after esophagectomy for cancer in the United States. Arch Surg 147(6):505–511

    Article  PubMed  Google Scholar 

  17. Olch PD (1960) Johann von MIKULICZ-RADECKI. Ann Surg 152:923–926

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Bonenkamp JJ, Hermans J, Sasako M et al (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340(12):908–914

    Article  CAS  PubMed  Google Scholar 

  19. Bonenkamp JJ, Songun I, Hermans J et al (1995) Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345(8952):745–748

    Article  CAS  PubMed  Google Scholar 

  20. McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J (2004) Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004(4):CD001964

    Google Scholar 

  21. Cuschieri A, Weeden S, Fielding J et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical co-operative group. Br J Cancer 79(9–10):1522–1530

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11(5):439–449

    Article  PubMed  Google Scholar 

  23. Degiuli M, Sasako M, Calgaro M et al (2004) Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian gastric cancer study group (IGCSG) randomised surgical trial. Eur J Surg Oncol 30(3):303–308

    Article  CAS  PubMed  Google Scholar 

  24. Degiuli M, Sasako M, Ponti A, Calvo F (2004) Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 90(9):1727–1732

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Karpeh MS, Leon L, Klimstra D, Brennan MF (2000) Lymph node staging in gastric cancer: is location more important than number? An analysis of 1,038 patients. Ann Surg 232(3):362–371

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Lee HK, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP (2001) Influence of the number of lymph nodes examined on staging of gastric cancer. Br J Surg 88(10):1408–1412

    Article  CAS  PubMed  Google Scholar 

  27. Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J (2002) How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer 94(11):2862–2866

    Article  PubMed  Google Scholar 

  28. Bilimoria KY, Talamonti MS, Wayne JD et al (2008) Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg 143(7):671–678 (discussion 678)

    Google Scholar 

  29. Baxter NN, Tuttle TM (2005) Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 12(12):981–987

    Article  PubMed  Google Scholar 

  30. Brennan MF, Kattan MW, Klimstra D, Conlon K (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240(2):293–298

    Article  PubMed  PubMed Central  Google Scholar 

  31. Yeo CJ, Cameron JL, Sohn TA et al (1999) Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 1999;229(5):613–622 (discussion 622–614)

    Google Scholar 

  32. Tomlinson JS, Jain S, Bentrem DJ et al (2007) Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg 142(8):767–723 (discussion 773–764)

    Google Scholar 

  33. Slidell MB, Chang DC, Cameron JL et al (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 15(1):165–174

    Article  PubMed  Google Scholar 

  34. Robinson SM, Rahman A, Haugk B et al (2012) Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. Eur J Surg Oncol 38(4):333–339

    Article  CAS  PubMed  Google Scholar 

  35. Malleo G, Maggino L, Capelli P et al (2015) Reappraisal of nodal staging and study of lymph node station involvement in pancreaticoduodenectomy with the standard international study group of pancreatic surgery definition of lymphadenectomy for cancer. J Am Coll Surg

    Google Scholar 

  36. Benson AB 3rd (2006) New approaches to the adjuvant therapy of colon cancer. Oncologist 11(9):973–980

    Article  CAS  PubMed  Google Scholar 

  37. Swanson RS, Compton CC, Stewart AK, Bland KI (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10(1):65–71

    Article  PubMed  Google Scholar 

  38. Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol Official J Am Soc Clin Oncol 17(9):2896–2900

    CAS  Google Scholar 

  39. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99(6):433–441

    Article  PubMed  Google Scholar 

  40. Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American pathologists consensus statement 1999. Arch Pathol Lab Med 124(7):979–994

    CAS  PubMed  Google Scholar 

  41. National Quality Forum. At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer. http://www.qualityforum.org/MeasureDetails.aspx?SubmissionId=455-k=colon. Last Accessed 20 July 2015

  42. American College of Surgeons, Cancer programs: cancer program practice profile reports (CP3R). http://www.facs.org/cancer/ncdb/cp3r.html. Last Accessed 22 July 2015

  43. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97(3):219–225

    Article  PubMed  Google Scholar 

  44. Bilimoria KY, Bentrem DJ, Stewart AK et al (2008) Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst 100(18):1310–1317

    Article  PubMed  PubMed Central  Google Scholar 

  45. American College of Surgeons, Cancer programs. CoC quality measures of care: national quality forum endorsed commission on cancer measures for quality of cancer care for breast and colorectal cancers. http://www.facs.org/cancer/qualitymeasures.html. Last Accessed 22 July 2015

  46. Parsons HM, Begun JW, Kuntz KM, Tuttle TM, McGovern PM, Virnig BA (2013) Lymph node evaluation for colon cancer in an era of quality guidelines: who improves? J Oncol Pract 9(4):e164–e171

    Article  PubMed  PubMed Central  Google Scholar 

  47. Heald RJ (1979) A new approach to rectal cancer. Br J Hosp Med 22(3):277–281

    CAS  PubMed  Google Scholar 

  48. Kapiteijn E, Putter H, van de Velde CJ (2002) Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 89(9):1142–1149

    Article  CAS  PubMed  Google Scholar 

  49. Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646

    Article  CAS  PubMed  Google Scholar 

  50. Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P (2005) Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol Official J Am Soc Clin Oncol 23(36):9257–9264

    Article  Google Scholar 

  51. Amajoyi R, Lee Y, Recio PJ, Kondylis PD (2013) Neoadjuvant therapy for rectal cancer decreases the number of lymph nodes harvested in operative specimens. Am J Surg. 205(3):289–292 (discussion 292)

    Google Scholar 

  52. Baxter NN, Morris AM, Rothenberger DA, Tepper JE (2005) Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys 61(2):426–431

    Article  PubMed  Google Scholar 

  53. Luna-Perez P, Rodriguez-Ramirez S, Alvarado I, Gutierrez de la Barrera M, Labastida S (2003) Prognostic significance of retrieved lymph nodes per specimen in resected rectal adenocarcinoma after preoperative chemoradiation therapy. Arch Med Res 34(4):281–286

    Google Scholar 

  54. Rullier A, Laurent C, Capdepont M et al (2008) Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol 32(1):45–50

    Article  PubMed  Google Scholar 

  55. Tsai CJ, Crane CH, Skibber JM et al (2011) Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer 117(16):3713–3722

    Article  PubMed  PubMed Central  Google Scholar 

  56. Bhangu A, Kiran RP, Brown G, Goldin R, Tekkis P (2014) Establishing the optimum lymph node yield for diagnosis of stage III rectal cancer. Tech Coloproctol 18(8):709–717

    Article  CAS  PubMed  Google Scholar 

  57. Park IJ, Yu CS, Lim SB et al (2014) Prognostic implications of the number of retrieved lymph nodes of patients with rectal cancer treated with preoperative chemoradiotherapy. J Gastrointest Surg 18(10):1845–1851

    Article  PubMed  Google Scholar 

  58. Raval MV, Bilimoria KY, Stewart AK, Bentrem DJ, Ko CY (2009) Using the NCDB for cancer care improvement: an introduction to available quality assessment tools. J Surg Oncol 99(8):488–490

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Chicago Division of Biological Sciences, Chicago, IL, USA

    Andrew Benjamin

  2. Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, C-1272, New York, NY, 10065, USA

    Ryan P. Merkow

Authors
  1. Andrew Benjamin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryan P. Merkow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryan P. Merkow .

Editor information

Editors and Affiliations

  1. Department of Surgery, Northwestern University, Chicago, Illinois, USA

    David Bentrem

  2. Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA

    Al B. Benson

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Benjamin, A., Merkow, R.P. (2016). Importance of Adequate Lymphadenectomy in Gastrointestinal Cancer. In: Bentrem, D., Benson, A. (eds) Gastrointestinal Malignancies. Cancer Treatment and Research. Springer, Cham. https://doi.org/10.1007/978-3-319-34244-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-34244-3_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-34242-9

  • Online ISBN: 978-3-319-34244-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation